OPHTHALMOLOGY - ois.net · financing retinal innovation moderated by: retinal consultants of...
Transcript of OPHTHALMOLOGY - ois.net · financing retinal innovation moderated by: retinal consultants of...
Emmett Cunningham, Jr., M.D., Ph.D., M.P.H.
Senior Managing Director
Blackstone Life Sciences
OPHTHALMOLOGYINNOVATION SUMMIT
0
200
400
600
800
1000
1200
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
OIS@AAO OIS@ASCRS OIS@ASRS
OIS@AAO> 1,10023 Meetings
~ 12,500 Attendees
OIS@ASCRS> 600
OIS@ASRS~ 300
5%
12%
4%
20%8%
5%
46% Academia, Government, or Association
Adviser, Consultant, or Service Provider
Finance/Investment Firm
Large Multi-National Corporation
Physician/Healthcare Provider
Press/Media
Start-up/Emerging Growth Company
OIS@ASRS 2019( > 280)
13 Countries23 US States
Save the Dates
@OISTWEETS #OISASRS
5th Annual OIS@ASRSSeattle, WA
July 23, 2020
/OIS.NETOIS: The Group for Ophthalmology
Innovation & Investment
9th Annual OIS@ASCRSBoston, MA
May 14, 2020
11th Annual OIS@AAOSan Francisco
October 10, 2019
2nd Annual OIS@SECOAtlanta, GA
March 4, 2020
EXCITING RESEARCH PROJECTS FUNDED BY
THE FOUNDATION FIGHTING BLINDNESS
INTRODUCED BY:
COOFOUNDATION FIGHTING
BLINDNESS
JASON MENZO
PUBLIC COMPANY SHOWCASE
INTRODUCED BY:
HEAD, NEW OPHTHALMIC PRODUCTS
SHIRE (A TAKEDA COMPANY)
SUSAN BENTON
FINANCING RETINAL INNOVATION
MODERATED BY:
RETINAL CONSULTANTSOF ARIZONA
PRAVIN DUGEL, MD
SENIOR MANAGING DIRECTOR BLACKSTONE LIFE SCIENCES
EMMETT T. CUNNINGHAM JR.,
MD, PHD, MPH
MANAGING DIRECTOR & HEAD, NORTH AMERICA
C-BRIDGE CAPITAL
MICHAEL KEYOUNG,
MD, PHDVENTURE PARTNER
PIVOTAL BIOVENTURE PARTNERS
ASH KHANNA, PHD
PARTNER - EXSIGHT VENTURES /PARTNER & EXECUTIVE - RETINA VITREOUS
ASSOCIATES MEDICAL GROUP
FIRAS M. RAHHAL, MD
MANAGING PARTNER - INFOCUS CAPITAL PARTNERS / FOUNDER &
OWNER - CHICAGO EYE CONSULTANTS
RON WEISS, MD
ADVANCEMENTS IN GENETIC & REGENERATIVE THERAPIES
PRESENTED BY:
ASSOCIATE PROFESSORUNIVERSITY OF CALIFORNIA, DAVIS
GLENN YIU, MD, PHD
GENETIC & REGENERATIVE THERAPY OVERVIEW
ADVANCEMENTS IN GENETIC & REGENERATIVE THERAPIES
MODERATED BY:
PARTNERILLINOIS RETINA ASSOCIATES
JOHN POLLACK, MD
CHIEF MEDICAL OFFICERCLEARSIDE BIOMEDICAL
THOMAS CIULLA, MD, MBA
PRESIDENT & CHIEFSCIENTIFIC OFFICER
ADVERUM BIOTECHNOLOGIES
MEHDI GASMI, PHD
PROFESSOR OF OPHTHALMOLOGYUNIVERSITY OF SOUTHERN
CALIFORNIA
MARK HUMAYUN, MD, PHD
SVP & CHIEF MEDICAL OFFICERREGENXBIO
STEVE PAKOLA, MD
ASSOCIATE PROFESSORUNIVERSITY OF CALIFORNIA, DAVIS
GLENN YIU, MD, PHD
PANEL DISCUSSION
RETINAL DRUG DELIVERY SOLUTIONS
MODERATED BY:
FOUNDERCALIFORNIA RETINA
CONSULTANTS
ROBERT AVERY, MDRETINA-VITREOUS ASSOCIATES
MEDICAL GROUP
DAVID BOYER, MD
DIRECTOR - NEW ENGLAND EYE CENTER / CO-FOUNDER -
HEMERA BIOSCIENCES
JAY DUKER, MD
PROFESSOR & CHAIR, DEPARTMENT OF OPHTHALMOLOGY, GAVIN HERBERT EYE INSTITUTE
UNIVERSITY OF CALIFORNIA, IRVINE
BARUCH KUPPERMANN, MD, PhD
PANEL DISCUSSION
GROUNDBREAKING DEVELOPMENTS IN AI & IMAGING
MODERATED BY:
FOUNDING DIRECTOR & CEO MIAMI OCULAR ONCOLOGY &
RETINA (MOOR)
TIMOTHY G. MURRAY, MDCO-FOUNDER & MEDICAL DIRECTOR
VITREOUS RETINA MACULA SPECIALISTS OF TORONTO
NETAN CHOUDHRY, MD
DIRECTOR, CLINICAL RESEARCH & CHIEF, RETINA SERVICE
WEILL CORNELL MEDICINE
SZILÁRD KISS, MD
PROFESSOR OF OPHTHALMOLOGY, DIRECTOR OF RETINA - STANFORD UNIVERSITY SCHOOL OF
MEDICINE / CO-FOUNDER - PR3VENT
DARIUS MOSHFEGHI, MD
PANEL DISCUSSION
RETINAL INDUSTRY LEADERS
MODERATED BY:
SENIOR MANAGING DIRECTOR BLACKSTONE LIFE SCIENCES
EMMETT T. CUNNINGHAM
JR., MD, PHD, MPH
GLOBAL HEAD, OPHTHALMOLOGY,CLINICAL DEVELOPMENT
GENENTECH
CHRISTOPHER BRITTAIN,
MRCOPHTH, MD, MBARETINAL SURGICAL
INSTRUMENTATION R&DALCON
RAVI DURVASULA, PHD
VP & GENERAL MANAGER, US SURGICALBAUSCH + LOMB
CHUCK HESS
GLOBAL HEAD, OPHTHALMIC DIAGNOSTICS
CARL ZEISS MEDITEC
ANGELO RAGO